Taiwan Semiconductor
TSM
420.22
+7.61
+1.84%
Taiwan Semiconductor
US · TSM
#7 by market cap
Listed 1997
420.22
+7.61
+1.84%
Live - 5344 symbols - heartbeat 87s ago
· 2026-10-20 06:39
✦ Quant Financial Health how this is computed
Fair
- Altman Z-Score is 2.97, in the 1.8-3.0 "grey zone".
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +31.61% YoY
Margins
- Gross margin
- 59.89%
- Operating margin
- 50.83%
- Net margin
- 44.57%
Key ratios & quality
- Enterprise valuei
- 84.35B
- PEG ratioi
- 1.43
- Altman Z-Scorei
- 2.97
PEG uses trailing P/E against the 3-year net income growth rate (19.58%/yr) since forward earnings estimates aren't available here, so this is not a "forward PEG." Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 1.03T | 1.07T | 1.34T | 1.59T | 2.26T | 2.16T | 2.89T | 3.81T |
| Gross profit | 497.87B | 492.70B | 711.13B | 819.54B | 1.35T | 1.18T | 1.62T | 2.28T |
| Selling & admin expenses | 26.25B | 28.09B | 35.57B | 44.49B | 63.45B | 71.46B | 96.89B | 99.22B |
| Research & development | 85.90B | 91.42B | 109.49B | 124.73B | 163.26B | 182.37B | 204.18B | 246.43B |
| Operating profit | 383.63B | 372.70B | 566.78B | 649.98B | 1.12T | 921.43B | 1.32T | 1.94T |
| Pretax profit | 397.54B | 389.86B | 584.75B | 663.04B | 1.14T | 979.32B | 1.41T | 2.04T |
| Tax | 34.44B | 35.84B | 73.74B | 70.16B | 150.78B | 128.29B | 248.32B | 346.53B |
| Net profit | 363.11B | 354.03B | 511.01B | 592.88B | 993.29B | 851.03B | 1.16T | 1.70T |
| Basic EPS | 70 | 68 | 99 | 114 | 191 | 164 | 223 | 327 |
| Diluted EPS | 70.00 | 68.25 | 98.50 | 114.20 | 191.45 | 164.25 | 223.35 | 327.35 |
| Line item | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 | 2026-09 |
|---|---|---|---|---|---|---|
| Revenue | 933.79B | 989.92B | 1.05T | 1.13T | 1.27T | 1.49T |
| Gross profit | 547.37B | 588.54B | 651.99B | 751.30B | 860.31B | 992.38B |
| Selling & admin expenses | 23.23B | 24.02B | 23.33B | 26.25B | 25.84B | -- |
| Research & development | 61.28B | 63.74B | 64.86B | 67.76B | 73.15B | -- |
| Operating profit | 463.44B | 500.69B | 564.88B | 658.95B | 766.57B | 876.45B |
| Pretax profit | 493.04B | 525.37B | 592.36B | 687.80B | 862.43B | 911.04B |
| Tax | 95.54B | 73.61B | 107.21B | 115.00B | 155.65B | -- |
| Net profit | 397.49B | 525.37B | 485.14B | 572.80B | 706.78B | 911.04B |
| Basic EPS | 77 | 87 | 98 | 110 | 136 | 147 |
| Diluted EPS | 76.80 | 87.20 | 97.50 | 110.40 | 136.25 | 147.13 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 951.68B | 822.61B | 1.09T | 1.61T | 2.05T | 2.19T | 3.09T | 3.82T |
| Cash & ST investments | 713.55B | 594.19B | 799.76B | 1.20T | 1.59T | 1.71T | 2.48T | 3.13T |
| Inventory | 103.23B | 82.98B | 137.35B | 193.10B | 221.15B | 251.00B | 287.87B | 288.11B |
| Total assets | 2.09T | 2.26T | 2.76T | 3.73T | 4.96T | 5.53T | 6.69T | 7.93T |
| Total current liabilities | 356.84B | 598.36B | 631.90B | 758.35B | 986.56B | 942.81B | 1.31T | 1.52T |
| Short-term debt | 123.65B | 150.32B | 91.16B | 119.49B | 19.31B | 9.29B | 59.86B | 136.93B |
| Long-term debt | 56.90B | 25.10B | 256.07B | 613.38B | 839.10B | 918.28B | 958.43B | 896.06B |
| Total liabilities | 428,926,100,000.00 | 650,337,700,000.00 | 924,836,700,000.00 | 1,573,619,700,000.00 | 2,046,626,700,000.00 | 2,078,330,100,000.00 | 2,412,493,100,000.00 | 2,536,623,300,000.00 |
| Total equity | 1.66T | 1.61T | 1.84T | 2.15T | 2.92T | 3.45T | 4.28T | 5.40T |
| Retained earnings | 1.06T | 1.00T | 1.22T | 1.52T | 2.28T | 2.82T | 3.56T | 4.64T |
| Line item | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 | 2026-09 |
|---|---|---|---|---|---|---|
| Total current assets | 3.26T | 3.44T | 3.82T | 4.27T | 4.57T | -- |
| Cash & ST investments | 2.68T | 2.80T | 3.13T | 3.45T | 3.60T | -- |
| Inventory | 304.19B | 288.69B | 288.11B | 311.45B | 385.52B | -- |
| Total assets | 7.01T | 7.35T | 7.93T | 8.66T | 9.38T | -- |
| Total current liabilities | 1.38T | 1.28T | 1.52T | 1.71T | 1.86T | -- |
| Short-term debt | 94.21B | 76.23B | 136.93B | 156.24B | 167.41B | -- |
| Long-term debt | 883.67B | 918.23B | 896.06B | 901.02B | 864.26B | -- |
| Total liabilities | 2,389,717,699,000.00 | 2,318,529,274,000.00 | 2,536,623,300,000.00 | 2,728,560,764,000.00 | 2,901,183,746,000.00 | -- |
| Total equity | 4.62T | 5.04T | 5.40T | 5.93T | 6.47T | -- |
| Retained earnings | 4.12T | 4.26T | 4.64T | 5.19T | 5.74T | -- |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 573.95B | 615.14B | 822.67B | 1.11T | 1.61T | 1.24T | 1.83T | 2.27T |
| Depreciation & amortization | 292.55B | 286.88B | 331.72B | 422.39B | 437.25B | 532.19B | 662.80B | 688.10B |
| Free cash flow | 251.27B | 145.39B | 301.19B | 262.72B | 520.97B | 286.57B | 861.20B | 992.38B |
| Dividends paid | -207.44B | -259.30B | -259.30B | -265.79B | -285.23B | -291.72B | -363.06B | -466.78B |
| Stock buybacks / issuance | -- | -- | 0 | 0 | -871.60M | 0 | -3.09B | 0 |
| Ending cash balance | 577.81B | 455.40B | 660.17B | 1.06T | 1.34T | 1.47T | 2.13T | 2.77T |
| Line item | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 | 2026-09 |
|---|---|---|---|---|---|---|
| Operating cash flow | 497.06B | 426.83B | 725.51B | 698.98B | 783.36B | -- |
| Depreciation & amortization | 188.06B | 162.79B | 162.11B | 165.45B | 198.54B | -- |
| Free cash flow | 199.84B | 138.39B | 364.04B | 347.27B | 274.97B | -- |
| Dividends paid | -116.70B | -116.70B | -129.66B | -129.66B | -155.60B | -- |
| Stock buybacks / issuance | -- | 0 | 0 | -- | -- | -- |
| Ending cash balance | 2.36T | 2.47T | 2.77T | 3.04T | 3.13T | -- |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 23.02 | 21.62 | 29.62 | 29.74 | 39.31 | 26.90 | 30.19 | 35.37 |
| ROA %i | 17.79 | 16.26 | 20.33 | 18.27 | 22.85 | 16.23 | 18.95 | 23.22 |
| ROIC %i | 19.86 | 18.78 | 25.19 | 23.19 | 29.39 | 19.81 | 22.64 | 27.67 |
| 5-year avg ROE %i | 25.59 | 24.43 | 24.89 | 25.64 | 28.66 | 29.44 | 31.15 | 32.30 |
| EBIT margin %i | 38.84 | 36.74 | 43.82 | 42.11 | 51.05 | 45.86 | 48.94 | 53.92 |
| FCF / sales %i | 24.36 | 13.59 | 22.49 | 16.55 | 23.01 | 13.26 | 29.75 | 26.05 |
| Current ratioi | 2.67 | 1.37 | 1.73 | 2.12 | 2.08 | 2.33 | 2.36 | 2.51 |
| Quick ratioi | 2.36 | 1.23 | 1.50 | 1.85 | 1.84 | 2.03 | 2.11 | 2.24 |
| Debt / assetsi | 8.64 | 8.41 | 13.32 | 20.23 | 17.89 | 17.29 | 15.65 | 13.42 |
| LT debt / equityi | 3.43 | 2.49 | 15.08 | 29.51 | 29.93 | 27.61 | 23.26 | 17.32 |
| Interest coveragei | 131.30 | 120.92 | 281.93 | 123.46 | 98.37 | 82.61 | 134.95 | 166.04 |
| Revenue CAGR (3Y) %i | 6.93 | 4.12 | 11.07 | 15.46 | 28.38 | 17.30 | 22.17 | 18.94 |
| Net income CAGR (3Y) %i | 6.23 | 2.19 | 13.97 | 17.73 | 41.03 | 18.59 | 25.05 | 19.58 |
| FCF CAGR (3Y) %i | -2.14 | -11.07 | 6.49 | 1.50 | 53.03 | -1.65 | 48.55 | 23.96 |
| Line item | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 | 2026-09 |
|---|---|---|---|---|---|---|
| ROE %i | 34.52 | 34.98 | 35.37 | 36.51 | 40.26 | -- |
| ROA %i | 22.25 | 23.25 | 23.22 | 24.17 | 27.06 | -- |
| ROIC %i | 26.42 | 29.62 | 27.67 | 28.96 | 32.57 | -- |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 51.99 | 52.60 | 53.92 | 56.31 | 60.35 | -- |
| FCF / sales %i | 27.32 | 24.33 | 26.05 | 25.52 | 25.33 | -- |
| Current ratioi | 2.37 | 2.69 | 2.51 | 2.49 | 2.46 | -- |
| Quick ratioi | 2.12 | 2.44 | 2.24 | 2.23 | 2.17 | -- |
| Debt / assetsi | 14.40 | 13.94 | 13.42 | 12.59 | 11.36 | -- |
| LT debt / equityi | 19.97 | 18.99 | 17.32 | 15.86 | 13.95 | -- |
| Interest coveragei | 153.41 | 161.18 | 166.04 | 186.22 | 227.02 | -- |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
Revenue breakdown most recent period
Business
Foundry segment100.00%
Quote time 2026-10-20 06:39:34 · For reference only, not investment advice and not tailored to your situation.
the whole AI chip stack runs through this company one way or another. geopolitics is the only real risk premium baked into the price at this point.